Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas

Gynecologic Oncology

Volumn 131, Issue 2, 2013, Pages 410-415

  Njølstad, Tormund S ^a   Engerud, Hilde ^a   Werner, Henrica M J ^a,b   Salvesen, Helga B ^a,b   Trovik, Jone ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Endometrial cancer; Leukocytosis; Preoperative anemia; Prognosis; Thrombocytosis

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN TISSUE; LEUKOCYTE; LEUKOCYTE COUNT; LEUKOCYTOSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOCYTOSIS;

ENDOMETRIAL CANCER; LEUKOCYTOSIS; PREOPERATIVE ANEMIA; PROGNOSIS; THROMBOCYTOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HEMOGLOBINS; HUMANS; LEUKOCYTE COUNT; LEUKOCYTOSIS; MIDDLE AGED; PLATELET COUNT; PREOPERATIVE PERIOD; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; THROMBOCYTOSIS; YOUNG ADULT;

EID: 84886092687     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.08.032     Document Type: Article

References (43)

1. Cancer in Norway Cancer incidence, mortality, survival and prevalence in Norway: Cancer Registry of Norway 2012
2. American Cancer Society Cancer facts & figures 2013 2013 American Cancer Society Atlanta
3. K. Lindemann, A. Eskild, L.J. Vatten, and F. Bray Endometrial cancer incidence trends in Norway during 1953-2007 and predictions for 2008-2027 Int J Cancer 127 11 2010 Dec 1 2661 2668
4. J.I. Sorosky Endometrial cancer Obstet Gynecol 120 2 Pt 1 2012 Aug 383 397
5. J. Prat Prognostic parameters of endometrial carcinoma Hum Pathol 35 6 2004 Jun 649 662
6. F. Amant, P. Moerman, P. Neven, D. Timmerman, E. Van Limbergen, and I. Vergote Endometrial cancer Lancet 366 9484 Aug 6-12 2005 491 505
7. H.B. Salvesen, I.S. Haldorsen, and J. Trovik Markers for individualised therapy in endometrial carcinoma Lancet Oncol 13 8 Aug 2012 e353 e361
8. A. Luomaranta, A. Leminen, and M. Loukovaara Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: a new model based on demographics, biochemical factors, and tumor histology Gynecol Oncol 129 1 Apr 2013 28 32
9. M.J. Worley Jr., C.C. Nitschmann, M. Shoni, A.F. Vitonis, J.A. Rauh-Hain, and C.M. Feltmate The significance of preoperative leukocytosis in endometrial carcinoma Gynecol Oncol 125 3 Jun 2012 561 565
10. K.F. Tamussino, F. Gucer, O. Reich, F. Moser, E. Petru, and H.S. Scholz Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma Int J Gynecol Cancer 11 3 May-Jun 2001 236 240
11. A. Ayhan, G. Bozdag, C. Taskiran, M. Gultekin, K. Yuce, and T. Kucukali The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma Gynecol Oncol 103 3 Dec 2006 902 905
12. J.J. Caro, M. Salas, A. Ward, and G. Goss Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review Cancer 91 12 Jun 15 2001 2214 2221
13. R.L. Stone, A.M. Nick, I.A. McNeish, F. Balkwill, H.D. Han, and J. Bottsford-Miller Paraneoplastic thrombocytosis in ovarian cancer N Engl J Med 366 7 Feb 16 2012 610 618
14. J. Trovik, E. Wik, I.M. Stefansson, J. Marcickiewicz, S. Tingulstad, and A.C. Staff Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer Clin Cancer Res 17 10 May 15 2011 3368 3377
15. B. de Benoist, E. McLean, I. Egli, and M. Cogswell Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia 2008 WHO Gèneve
16. H. Ludwig, S. Van Belle, P. Barrett-Lee, G. Birgegard, C. Bokemeyer, and P. Gascon The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients Eur J Cancer 40 15 Oct 2004 2293 2306
17. User Manual Medical Biochemistry, Norway Leukocytes, blood 02.12.2010 (www.prosedyrer.no.)
18. User Manual Medical Biochemistry, Norway Platelets, blood 02.12.2010 (www.prosedyrer.no.)
19. L.C. Pelosof, and D.E. Gerber Paraneoplastic syndromes: an approach to diagnosis and treatment Mayo Clin Proc 85 9 Sep 2010 838 854
20. G. Weiss, and L.T. Goodnough Anemia of chronic disease N Engl J Med 352 10 Mar 10 2005 1011 1023
21. A.A. Ashour, C.F. Verschraegen, A.P. Kudelka, and J.J. Kavanagh Paraneoplastic syndromes of gynecologic neoplasms J Clin Oncol 15 3 Mar 1997 1272 1282
22. J. Metindir, and Dilek G. Bilir Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma J Cancer Res Clin Oncol 135 1 Jan 2009 125 129
23. M.Z. Qiu, R.H. Xu, D.Y. Ruan, Z.H. Li, H.Y. Luo, and K.Y. Teng Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China Tumour Biol 31 6 Dec 2010 633 641
24. K. Matsuo, A.A. Yessaian, Y.G. Lin, H.Q. Pham, L.I. Muderspach, and H.A. Liebman Predictive model of venous thromboembolism in endometrial cancer Gynecol Oncol 128 3 Mar 2013 544 551
25. M.Z. Qiu, Z.Y. Yuan, H.Y. Luo, D.Y. Ruan, Z.Q. Wang, and F.H. Wang Impact of pretreatment hematologic profile on survival of colorectal cancer patients Tumour Biol 31 4 Aug 2010 255 260
26. C. Cordella, H.T. Luebbers, V. Rivelli, K.W. Gratz, and A.L. Kruse An evaluation of the preoperative hemoglobin level as a prognostic factor for oral squamous cell carcinoma Head Neck Oncol 3 2011 35
27. M. Tomita, T. Shimizu, M. Hara, T. Ayabe, and T. Onitsuka Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients Anticancer Res 28 3B May-Jun 2008 1947 1950
28. G. Holgersson, M. Sandelin, E. Hoye, S. Bergstrom, R. Henriksson, and S. Ekman Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer Med Oncol 29 5 Dec 2012 3176 3182
29. C.G. Gerestein, M.J. Eijkemans, D. de Jong, M.E. van der Burg, R.H. Dykgraaf, and G.S. Kooi The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma BJOG 116 3 Feb 2009 372 380
30. K.H. Seo, H.S. Lee, B. Jung, H.M. Ko, J.H. Choi, and S.J. Park Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation Cancer Res 64 18 Sep 15 2004 6482 6488
31. M.E. Hardee, M.O. Arcasoy, K.L. Blackwell, J.P. Kirkpatrick, and M.W. Dewhirst Erythropoietin biology in cancer Clin Cancer Res 12 2 Jan 15 2006 332 339
32. Y. Yasuda, Y. Fujita, S. Masuda, T. Musha, K. Ueda, and H. Tanaka Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs Carcinogenesis 23 11 Nov 2002 1797 1805
33. G. Acs, X. Xu, C. Chu, P. Acs, and A. Verma Prognostic significance of erythropoietin expression in human endometrial carcinoma Cancer 100 11 Jun 1 2004 2376 2386
34. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 6 Mar 19 2010 883 899
35. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 5 Mar 4 2011 646 674
36. S. Mabuchi, Y. Matsumoto, F. Isohashi, Y. Yoshioka, H. Ohashi, and E. Morii Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer Gynecol Oncol 122 1 Jul 2011 25 32
37. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 1 Jan 7 2000 57 70
38. F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 30 7 Jul 2009 1073 1081
39. A.E. Wallace, D.A. Gibson, P.T. Saunders, and H.N. Jabbour Inflammatory events in endometrial adenocarcinoma J Endocrinol 206 2 Aug 2010 141 157
40. R.J. Delahanty, Y.B. Xiang, A. Spurdle, A. Beeghly-Fadiel, J. Long, and D. Thompson Polymorphisms in inflammation pathway genes and endometrial cancer risk Cancer Epidemiol Biomarkers Prev 22 2 Feb 2013 216 223
41. H.B. Salvesen, and L.A. Akslen Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas Int J Cancer 84 5 Oct 22 1999 538 543
42. C. Gorelick, V. Andikyan, M. Mack, Y.C. Lee, and O. Abulafia Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population Int J Gynecol Cancer 19 8 Nov 2009 1384 1389
43. E.A. Akl, F.F. van Doormaal, M. Barba, G. Kamath, S.Y. Kim, and S. Kuipers Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation Cochrane Database Syst Rev 3 2007 CD006652